190 related articles for article (PubMed ID: 20961888)
1. The role of graft-versus-host disease in haematopoietic cell transplantation-associated glomerular disease.
Hu SL
Nephrol Dial Transplant; 2011 Jun; 26(6):2025-31. PubMed ID: 20961888
[TBL] [Abstract][Full Text] [Related]
2. Nephrotic syndrome after hematopoietic cell transplantation: do glomerular lesions represent renal graft-versus-host disease?
Brukamp K; Doyle AM; Bloom RD; Bunin N; Tomaszewski JE; Cizman B
Clin J Am Soc Nephrol; 2006 Jul; 1(4):685-94. PubMed ID: 17699273
[TBL] [Abstract][Full Text] [Related]
3. Neurological manifestations of chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: report from the Consensus Conference on Clinical Practice in chronic graft-versus-host disease.
Grauer O; Wolff D; Bertz H; Greinix H; Kühl JS; Lawitschka A; Lee SJ; Pavletic SZ; Holler E; Kleiter I
Brain; 2010 Oct; 133(10):2852-65. PubMed ID: 20846944
[TBL] [Abstract][Full Text] [Related]
4. Clinicopathologic analysis of renal biopsies after haematopoietic stem cell transplantation.
Chan GS; Lam MF; Au WY; Chim S; Tse KC; Lo SH; Fung SH; Lai KN; Chan KW
Nephrology (Carlton); 2008 Jun; 13(4):322-30. PubMed ID: 18221254
[TBL] [Abstract][Full Text] [Related]
5. Post-allogeneic haematopoietic stem cell transplantation membranous nephropathy: clinical presentation, outcome and pathogenic aspects.
Terrier B; Delmas Y; Hummel A; Presne C; Glowacki F; Knebelmann B; Combe C; Lesavre P; Maillard N; Noël LH; Patey-Mariaud de Serre N; Nusbaum S; Radford I; Buzyn A; Fakhouri F
Nephrol Dial Transplant; 2007 May; 22(5):1369-76. PubMed ID: 17255123
[TBL] [Abstract][Full Text] [Related]
6. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
7. [Clinical analysis of late-onset nephrotic syndrome after allogenic hematopoietic stem cell transplantation].
Luo XD; Liu QF; Ning J; Wei YQ; Fan ZP; Zhang Y; Sun J
Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(46):3280-3. PubMed ID: 18396625
[TBL] [Abstract][Full Text] [Related]
8. The impact of histopathologic examination of graft-versus-host disease in the era of reduced-intensity conditioning regimen: a study from the Gruppo Italiano Trapianto di Midollo Osseo.
Massi D; Fondi C; Nozzoli C; Benemei S; Lapi F; Albarello L; Avellini C; Bonoldi E; Casini M; Cesinaro AM; Ciceri F; Colombetti V; Comin CE; Donelli A; Fortunato M; Fratoni S; Guidi S; Messerini L; Milone G; Rapezzi D; Negri G; Patriarca F; Peccatori FA; Ponzoni M; Rafaniello P; Raimondi R; Salomone E; Tendas A; Villari L; Santucci M; Bosi A
Hum Pathol; 2011 Feb; 42(2):254-68. PubMed ID: 21106223
[TBL] [Abstract][Full Text] [Related]
9. [Allogeneic hematopoietic stem cell transplantation in patients with chronic myeloid leukemia in the Czech Republic--a retrospective analysis of results in years 1988-2005].
Faber E; Koza V; Vítek A; Mayer J; Sedlácek P; Zák P; Zapletalová J; Benesová K; Krejcová H; Steinerová K; Maresová I; Cetkovský P
Vnitr Lek; 2006 Dec; 52(12):1172-80. PubMed ID: 17299910
[TBL] [Abstract][Full Text] [Related]
10. Thalidomide after allogeneic haematopoietic stem cell transplantation: activity in chronic but not in acute graft-versus-host disease.
Kulkarni S; Powles R; Sirohi B; Treleaven J; Saso R; Horton C; Atra A; Ortin M; Rudin C; Goyal S; Sankpal S; Meller S; Pinkerton CR; Mehta J; Singhal S
Bone Marrow Transplant; 2003 Jul; 32(2):165-70. PubMed ID: 12838281
[TBL] [Abstract][Full Text] [Related]
11. Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.
Horwitz ME; Barrett AJ; Brown MR; Carter CS; Childs R; Gallin JI; Holland SM; Linton GF; Miller JA; Leitman SF; Read EJ; Malech HL
N Engl J Med; 2001 Mar; 344(12):881-8. PubMed ID: 11259721
[TBL] [Abstract][Full Text] [Related]
12. Nephrotic syndrome after allogeneic hematopoietic stem cell transplantation as a late complication of chronic graft-versus-host disease.
Colombo AA; Rusconi C; Esposito C; Bernasconi P; Caldera D; Lazzarino M; Alessandrino EP
Transplantation; 2006 Apr; 81(8):1087-92. PubMed ID: 16641591
[TBL] [Abstract][Full Text] [Related]
13. Graft-versus-host disease in children who have received a cord-blood or bone marrow transplant from an HLA-identical sibling. Eurocord and International Bone Marrow Transplant Registry Working Committee on Alternative Donor and Stem Cell Sources.
Rocha V; Wagner JE; Sobocinski KA; Klein JP; Zhang MJ; Horowitz MM; Gluckman E
N Engl J Med; 2000 Jun; 342(25):1846-54. PubMed ID: 10861319
[TBL] [Abstract][Full Text] [Related]
14. Eczematoid graft-vs-host disease: a novel form of chronic cutaneous graft-vs-host disease and its response to psoralen UV-A therapy.
Creamer D; Martyn-Simmons CL; Osborne G; Kenyon M; Salisbury JR; Devereux S; Pagliuca A; Ho AY; Mufti GJ; du Vivier AW
Arch Dermatol; 2007 Sep; 143(9):1157-62. PubMed ID: 17875877
[TBL] [Abstract][Full Text] [Related]
15. Early-onset lichenoid graft-vs.-host disease: a unique variant of acute graft-vs.-host disease occurring in peripheral blood stem cell transplant recipients.
Magro CM; Kerns MJ; Votava H; Vasil KE; Dyrsen ME; Morrison CD
J Cutan Pathol; 2010 May; 37(5):549-58. PubMed ID: 19843195
[TBL] [Abstract][Full Text] [Related]
16. [Influence of graft-versus-host disease on long-term survival of 26 patients with hematologic malignancies after transplantation].
Lin Q; Dong M; Wang QM; Wen JY; Wu XY
Ai Zheng; 2006 Oct; 25(10):1261-5. PubMed ID: 17059772
[TBL] [Abstract][Full Text] [Related]
17. Allogeneic stem cell transplantation as treatment for heavily treated, refractory acute graft-versus-host disease after HLA-mismatched stem cell transplantation.
Ikegame K; Yoshihara S; Taniguchi Y; Kaida K; Inoue T; Okada M; Taniguchi K; Hasei H; Tamaki H; Fujioka T; Kato R; Soma T; Ogawa H
Exp Hematol; 2011 Aug; 39(8):880-90. PubMed ID: 21689724
[TBL] [Abstract][Full Text] [Related]
18. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
[TBL] [Abstract][Full Text] [Related]
19. Low incidence of severe acute graft-versus-host disease in children given haematopoietic stem cell transplantation from unrelated donors prospectively matched for HLA class I and II alleles with high-resolution molecular typing.
Giebel S; Giorgiani G; Martinetti M; Zecca M; Maccario R; Salvaneschi L; Holowiecki J; Locatelli F
Bone Marrow Transplant; 2003 Jun; 31(11):987-93. PubMed ID: 12774049
[TBL] [Abstract][Full Text] [Related]
20. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
